SCHEMBL192955

SCHEMBL192955

O=C(CBr)C1=NOC(c2c(F)cccc2F)C1

nearest known ligand 0.35

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
PTPN1 P18031 2/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GSK3B P49841 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19525864 1.00 POLB (0.35) POLBNPC1RAB9APTPN1MEN1
SCHEMBL10163553 0.86 POLB (0.35) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL564213 0.86 POLB (0.35) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL19525865 0.81 POLB (0.38) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL193085 0.81 POLB (0.38) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL3689235 0.78 TSHR (0.47) PTPN1GSK3B
SCHEMBL3680890 0.78 TSHR (0.47) PTPN1GSK3B
SCHEMBL192351 0.78 POLB (0.37) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL19525866 0.78 POLB (0.37) POLBNPC1RAB9AMEN1KMT2A
SCHEMBL28632237 0.74 LMNA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669277-B2 Solid forms of an azocyclic amide E I DU PONT DE NEMOURS AND COMPANY (US) 2014-03-11 US claimed
EP-2421861-B1 SOLID FORMS OF AN AZOCYCLIC AMIDE DU PONT (US) 2013-01-16 EP claimed
EP-2421861-A1 SOLID FORMS OF AN AZOCYCLIC AMIDE E. I. du Pont de Nemours and Company (US) 2012-02-29 EP claimed
US-20120034315-A1 SOLID FORMS OF AN AZOCYCLIC AMIDE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2012-02-09 US claimed
WO-2010123791-A1 SOLID FORMS OF AN AZOCYCLIC AMIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-28 WO claimed
CN-114685481-A Preparation method of oxathiapiprolin 南通泰禾化工股份有限公司 2022-07-01 CN disclosed
EP-3265446-B1 PROCESS FOR PREPARING SUBSTITUTED PHENYLISOXAZOLINE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2019-08-14 EP disclosed
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-02-01 US disclosed
US-9090604-B2 Fungicidal azocyclic amides E I DU PONT DE NEMOURS AND COMPANY (US) 2015-07-28 US disclosed
US-9090604-B2 Fungicidal azocyclic amides E I DU PONT DE NEMOURS AND COMPANY (US) 2015-07-28 US disclosed
US-9062040-B2 Solid forms of an azocyclic amide E I DU PONT DE NEMOURS AND COMPANY (US) 2015-06-23 US disclosed
EP-2521450-B1 FUNGICIDAL HETEROCYCLIC COMPOUNDS DU PONT (US) 2015-02-25 EP disclosed
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (DE) 2011-09-15 US disclosed
EP-2358709-A2 FUNGICIDAL HETEROCYCLIC COMPOUNDS E. I. du Pont de Nemours and Company (US) 2011-08-24 EP disclosed
WO-2011085170-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2011-07-14 WO disclosed
EP-2260032-A2 FUNGICIDAL HETERCYCLIC COMPOUNDS E. I. du Pont de Nemours and Company (US) 2010-12-15 EP disclosed
US-20100292275-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-11-18 US disclosed
WO-2010123791-A1 SOLID FORMS OF AN AZOCYCLIC AMIDE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-28 WO disclosed
WO-2010065579-A2 FUNGICIDAL HETEROCYCLIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2010-06-10 WO disclosed
WO-2009094445-A2 FUNGICIDAL HETERCYCLIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224258-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS NOX1, XDH, CBR1 POLB 4340/4885NPC1 961/4885RAB9A 664/4885
US-20100292275-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS CYP1B1, CBR1, NOX1 POLB 4093/4885NPC1 262/4885RAB9A 863/4885
US-20180030002-A1 Process for preparing substituted phenylisoxazoline derivatives CYP3A7, CYP3A4, CYP4X1 POLB 1028/4885NPC1 2178/4885RAB9A 3725/4885
US-20120034315-A1 SOLID FORMS OF AN AZOCYCLIC AMIDE NOD1, NUAK1, DDT POLB 3860/4885NPC1 285/4885RAB9A 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.